Pullix (PLX) Rockets Past Spinoff (INJ) and Ripple (XRP) with Unprecedented Market Momentum

Pullix (PLX) has recently taken center stage in the DeFi market. Many analysts have pegged this six-stage pre-sale project as the next 100x altcoin in 2024. But could this shake up popular players like Injective (INJ) and Ripple (XRP)? Today we will take a look at all three of these DeFi coins and find out.

Pullix (PLX): Innovative DeFi project

Pullix (PLX) is gaining attention as it is already offering 100% ROI to its early backers. This is causing millions of global traders to flock to this new ICO event, which has already raised $3.6 million.

Investors are excited about this DeFi project, which could revolutionize online trading. Pullix will build the world’s first hybrid trading platform that combines the advantages of DEX and CEX. This innovative approach eliminates many of the problems affecting this market. For example, Pullix charges a 0% commission on trades, so you don’t have to worry about high trading fees.

Additionally, other interesting aspects may excite traders, such as:

• exchange: Pullix Swap allows you to swap tokens with minimal fees.
• Access to all assets: Unlike Binance, Pullix allows you to trade all asset classes (including cryptocurrencies) from one account.

The PLX native token is the main currency used for trading on Pullix. Additionally, PLX is the first “transaction-yield” cryptocurrency. By staking these altcoins, you will receive a daily percentage of Pullix profits. Additionally, the team plans to implement a burn function to significantly reduce PLX supply and increase its value. This is good news for long-term PLX token holders.

For all these reasons, more than 69 million PLX tokens have been sold so far. Currently, the price of one PLX is only $0.08, but its value will rise as the pre-sale progresses. market analysts 100 times This altcoin will soar when it is listed on the exchange in the first quarter of 2024. This price prediction is very possible with respect to the OTC derivatives market being worth $618 trillion by 2022.

Injective launches Volan upgrade

Meanwhile, last week saw some interesting Injective news as they released a new Volan upgrade. According to it official announcementThis upgrade redefines Injective’s real-world assets, institutional adoption, scalability, and more.

Looking at the value movement of Injective Coin, it has been showing an upward trend recently. You can see a 28% rise on the monthly chart. This altcoin has fluctuated between $31 and $39 during that period. Likewise, Injective market capitalization increased from $2.59 billion to $3.3 billion.

Market analysts predict that Injective will trade at the $53.99 level within the second quarter of 2024, using 24 green technology indicators.

Ripple XRP Healthcare Becomes XRPL Validator

Ripple XRP Healthcare (XRPH) announced its latest achievements as a validator node within the XRP Ledger (XRPL) network. This notable achievement demonstrates the platform’s commitment to transparency.

The Ripple cryptocurrency is trading in the green on the weekly chart. It moved between $0.56 and $0.57 levels. Meanwhile, its market capitalization surged from $30.66 billion to $31.45 billion during that period.

With this altcoin trading above its 100-day and 200-day EMA, experts are confident that Ripple could surge to $0.81 within the second quarter of 2024.

Can Pullix rise faster than Injective and Ripple?

Looking at all these altcoins, it is clear that Pullix has a competitive advantage: low market capitalization. The current price is $16 million. That means you only need $16 million more to double the current price. Therefore, this new ICO will deliver faster and more significant profits than Injective and Ripple.